In summary, these results indicate that ATCV-1 SOD1 augments production of inflammatory factors IL-6 and NO, and ISG expression, which are associated with development of ALS in humans and MND in SODG93A transgenic mice. Here, IL6 is linked to mild neurocognitive disorder.